Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
28,961,082
-
Total 13F shares
-
289,053
-
Share change
-
+82,695
-
Total reported value
-
$243,384
-
Price per share
-
$0.84
-
Number of holders
-
16
-
Value change
-
+$35,117
-
Number of buys
-
10
-
Number of sells
-
4
Institutional Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q4 2022
As of 31 Dec 2022,
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
289,053 shares.
The largest 10 holders included
New Leaf Venture Partners, L.L.C., DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, Krilogy Financial LLC, FRANKLIN RESOURCES INC, UBS Group AG, MORGAN STANLEY, Focused Wealth Management, Inc, and Tower Research Capital LLC (TRC).
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.